To research Medicaid spending on prescription drugs under the Food and Drug Administration’s accelerated approval pathway with unclear clinical benefits.
2020 - 2022
Arnold Ventures funds projects to understand problems and identify policy solutions.
Have an evidence-based week
Get The Abstract from Arnold Ventures delivered to your inbox.